Form 4: PegaSystems Chief Product Officer Rifat Kerim Akgonul Reports Stock Sales and RSU Vesting
SEC Form 4 Filing
Rifat Kerim Akgonul, Chief Product Officer of PegaSystems, reports multiple transactions involving the sale of common stock and vesting of restricted stock units (RSUs) between March 1 and March 4, 2024.
Summary
- Rifat Kerim Akgonul, the Chief Product Officer of PegaSystems, filed a Form 4 detailing changes in beneficial ownership.
- The transactions include the sale of PegaSystems common stock at prices ranging from $64.50 to $66.93 per share.
- A total of 200 shares were sold at $64.50, 1,250 shares at a weighted average of $66.47, and 550 shares at a weighted average of $66.93 on March 1, 2024.
- Additionally, RSUs vested on March 1 and March 4, resulting in the acquisition of 588, 231, and 335 shares respectively.
- Shares were also tendered to the issuer to satisfy tax withholding obligations.
- These sales were executed under a pre-arranged trading plan adopted on November 9, 2023, under Rule 10b5-1.
- Following these transactions, Akgonul directly owns 51,844 shares of PegaSystems common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions are part of a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook on the company.
Positives
- The sales were conducted under a pre-arranged trading plan, suggesting they were planned in advance and not based on immediate insider knowledge.
Risks
- While the sales are under a pre-arranged plan, large volumes of insider selling could potentially create negative market sentiment.
Industry Context
Insider trading activity is closely monitored by investors as it can provide insights into management's perspective on the company's valuation and future prospects; however, pre-arranged trading plans mitigate concerns about trading on inside information.
Stakeholder Impact
- Shareholders may monitor insider selling activity for signals about management's confidence in the company.
- The impact on employees is likely minimal unless the selling activity is perceived as a lack of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 2021-03-03 | Original grant date for 6,687 restricted stock units, with 20% vesting on March 3, 2021, and the remaining 80% vesting in equal quarterly installments over the remaining four years. |
| 2022-03-02 | Original grant date for 4,611 restricted stock units, with a 20% vesting on March 2, 2022, with the remaining 80% vesting in equal quarterly installments over the remaining four years. |
| 2023-03-01 | 20% vesting on March 1, 2023, for an original grant of 11,754 restricted stock units, with the remaining 80% vesting in equal quarterly installments over the remaining four years. |
| 2023-11-09 | Date of adoption of the pre-arranged trading plan under Rule 10b5-1. |
| 2024-03-01 | Sale of 200 shares at $64.50, 1,250 shares at $66.47, 550 shares at $66.93, and vesting of 588 RSUs. |
| 2024-03-04 | Vesting of 231 and 335 RSUs, and release date for shares from vesting on March 2 and March 3. |
| 2024-03-05 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.